2010
DOI: 10.4253/wjge.v2.i2.75
|View full text |Cite
|
Sign up to set email alerts
|

Trimming of a migrated metal stent for malignant colonic stricture using argon plasma coagulation

Abstract: We report the first case of trimming of a migrated metal colonic stent for stent induced severe anorectal pain. We present a case of a 54-year-old female with history of metastatic colorectal carcinoma who had stent placement secondary to obstruction. Subsequent distal migration of the stent caused ulcerations into the rectal mucosa and excruciating anorectal pain. We used argon plasma coagulation (APC) to successfully trim the exposed distal portion of the metal stent and rat tooth forceps to retrieve the ste… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 4 publications
0
3
0
Order By: Relevance
“…The most feared major complication is perforation. Chemotherapy increases the risk of it occurring (20). The most common major complication is stent obstruction due to tumor ingrowth, with a incidence of 10% (17).…”
Section: Discussionmentioning
confidence: 99%
“…The most feared major complication is perforation. Chemotherapy increases the risk of it occurring (20). The most common major complication is stent obstruction due to tumor ingrowth, with a incidence of 10% (17).…”
Section: Discussionmentioning
confidence: 99%
“…Endoscopic removal of a covered stent may be performed in cases in which stent migration to the anorectal area results in pain or irritation. In the case of uncovered stent migration, argon plasma coagulation combined with rat-tooth forceps has been used [35] . Avoidance of stent migration is frequently achieved by placing the stent in the center of the stricture (or slightly above) and ensuring that it projects 2 to 4 cm proximally and distally into normal colon [18] .…”
Section: Major Complicationsmentioning
confidence: 99%
“…Faragher et al [16] reported an increased complication rate of 34.8% in patients receiving bevacizumab following stenting as compared to a 22.8% in untreated patients. This association may have also contributed to the high perforation rate in the stented group that lead to the premature termination of the only randomized controlled trial that attempted to compare outcomes between surgical intervention and SEMS in stage IV colon cancer patients on chemotherapy [35] . Chemotherapeutic agents, in particular bevacizumab, have been linked to an increased risk of colonic perforation [35] .…”
Section: Perforationmentioning
confidence: 99%